RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/25823027http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/25823027http://www.w3.org/2000/01/rdf-schema#comment"Whole-genome and transcriptome sequencing were used to discover novel gene fusions in a case of colon cancer. A tumor-specific LACTB2-NCOA2 fusion originating from intra-chromosomal rearrangement of chromosome 8 was identified at both DNA and RNA levels. Unlike conventional oncogenic chimeric proteins, the fusion product lacks functional domain from respective genes, indicative of an amorphic rearrangement. This chimeric LACTB2-NCOA2 transcript was detected in 6 out of 99 (6.1%) colorectal cancer (CRC) cases, where NCOA2 was significantly downregulated. Enforced expression of wild-type NCOA2 but not the LACTB2-NCOA2 fusion protein impaired the pro-tumorigenic phenotypes of CRC cells, whereas knockdown of endogenous NCOA2 in normal colonocytes had opposite effects. Mechanistically, NCOA2 inhibited Wnt/β-catenin signaling through simultaneously upregulating inhibitors and downregulating stimulators of Wnt/β-catenin pathway. Collectively, our data supports that NCOA2 is a novel negative growth regulatory gene repressing the Wnt/β-catenin pathway in CRC, where recurrent fusion with LACTB2 contributes to its disruption."xsd:string
http://purl.uniprot.org/citations/25823027http://purl.org/dc/terms/identifier"doi:10.1038/onc.2015.72"xsd:string
http://purl.uniprot.org/citations/25823027http://purl.uniprot.org/core/author"He J."xsd:string
http://purl.uniprot.org/citations/25823027http://purl.uniprot.org/core/author"Liang Q."xsd:string
http://purl.uniprot.org/citations/25823027http://purl.uniprot.org/core/author"Li X."xsd:string
http://purl.uniprot.org/citations/25823027http://purl.uniprot.org/core/author"Zhang X."xsd:string
http://purl.uniprot.org/citations/25823027http://purl.uniprot.org/core/author"Xu L."xsd:string
http://purl.uniprot.org/citations/25823027http://purl.uniprot.org/core/author"Sung J.J."xsd:string
http://purl.uniprot.org/citations/25823027http://purl.uniprot.org/core/author"Yu J."xsd:string
http://purl.uniprot.org/citations/25823027http://purl.uniprot.org/core/author"Zhang N."xsd:string
http://purl.uniprot.org/citations/25823027http://purl.uniprot.org/core/author"Ng S.S."xsd:string
http://purl.uniprot.org/citations/25823027http://purl.uniprot.org/core/author"Chan M.T."xsd:string
http://purl.uniprot.org/citations/25823027http://purl.uniprot.org/core/author"Wu W.K."xsd:string
http://purl.uniprot.org/citations/25823027http://purl.uniprot.org/core/date"2016"xsd:gYear
http://purl.uniprot.org/citations/25823027http://purl.uniprot.org/core/name"Oncogene"xsd:string
http://purl.uniprot.org/citations/25823027http://purl.uniprot.org/core/pages"187-195"xsd:string
http://purl.uniprot.org/citations/25823027http://purl.uniprot.org/core/title"Disruption of NCOA2 by recurrent fusion with LACTB2 in colorectal cancer."xsd:string
http://purl.uniprot.org/citations/25823027http://purl.uniprot.org/core/volume"35"xsd:string
http://purl.uniprot.org/citations/25823027http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/25823027
http://purl.uniprot.org/citations/25823027http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/25823027
http://purl.uniprot.org/uniprot/#_A0A024R811-mappedCitation-25823027http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/25823027
http://purl.uniprot.org/uniprot/#_Q15596-mappedCitation-25823027http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/25823027
http://purl.uniprot.org/uniprot/#_A0A0B6XJZ8-mappedCitation-25823027http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/25823027
http://purl.uniprot.org/uniprot/#_A3FFT2-mappedCitation-25823027http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/25823027